Synthetic studies of neoclerodane diterpenes from Salvia divinorum: role of the furan in affinity for opioid receptors
- PMID: 19707679
- PMCID: PMC3025038
- DOI: 10.1039/b905148a
Synthetic studies of neoclerodane diterpenes from Salvia divinorum: role of the furan in affinity for opioid receptors
Abstract
Further synthetic modification of the furan ring of salvinorin A (1), the major active component of Salvia divinorum, has resulted in novel neoclerodane diterpenes with opioid receptor affinity and activity. A computational study has predicted 1 to be a reproductive toxicant in mammals and is suggestive that use of 1 may be associated with adverse effects. We report in this study that piperidine 21 and thiomorpholine 23 have been identified as selective partial agonists at kappa opioid receptors. This indicates that additional structural modifications of 1 may provide ligands with good selectivity for opioid receptors but with reduced potential for toxicity.
Figures



Similar articles
-
Synthetic studies of neoclerodane diterpenes from Salvia divinorum: preparation and opioid receptor activity of salvinicin analogues.J Med Chem. 2007 Jul 26;50(15):3596-603. doi: 10.1021/jm070393d. Epub 2007 Jun 20. J Med Chem. 2007. PMID: 17580847
-
Synthetic studies of neoclerodane diterpenes from Salvia divinorum: selective modification of the furan ring.Bioorg Med Chem Lett. 2006 Jun 15;16(12):3170-4. doi: 10.1016/j.bmcl.2006.03.062. Epub 2006 Apr 18. Bioorg Med Chem Lett. 2006. PMID: 16621556
-
Neoclerodane diterpenes as a novel scaffold for mu opioid receptor ligands.J Med Chem. 2005 Jul 28;48(15):4765-71. doi: 10.1021/jm048963m. J Med Chem. 2005. PMID: 16033256
-
Salvinorin A analogs and other κ-opioid receptor compounds as treatments for cocaine abuse.Adv Pharmacol. 2014;69:481-511. doi: 10.1016/B978-0-12-420118-7.00012-3. Adv Pharmacol. 2014. PMID: 24484985 Free PMC article. Review.
-
Neoclerodanes as atypical opioid receptor ligands.J Med Chem. 2013 May 9;56(9):3435-43. doi: 10.1021/jm400388u. Epub 2013 Apr 18. J Med Chem. 2013. PMID: 23548164 Free PMC article. Review.
Cited by
-
A review of salvinorin analogs and their kappa-opioid receptor activity.Bioorg Med Chem Lett. 2018 May 15;28(9):1436-1445. doi: 10.1016/j.bmcl.2018.03.029. Epub 2018 Mar 12. Bioorg Med Chem Lett. 2018. PMID: 29615341 Free PMC article. Review.
-
Solving an Old Puzzle: Elucidation and Evaluation of the Binding Mode of Salvinorin A at the Kappa Opioid Receptor.Molecules. 2023 Jan 11;28(2):718. doi: 10.3390/molecules28020718. Molecules. 2023. PMID: 36677775 Free PMC article.
-
Potential Drug Abuse Therapeutics Derived from the Hallucinogenic Natural Product Salvinorin A.Medchemcomm. 2011 Dec;2(12):1217-1222. doi: 10.1039/C1MD00192B. Medchemcomm. 2011. PMID: 22442751 Free PMC article.
-
Neuropharmacology of the naturally occurring kappa-opioid hallucinogen salvinorin A.Pharmacol Rev. 2011 Jun;63(2):316-47. doi: 10.1124/pr.110.003244. Epub 2011 Mar 28. Pharmacol Rev. 2011. PMID: 21444610 Free PMC article. Review.
-
Opioid receptor probes derived from cycloaddition of the hallucinogen natural product salvinorin A.J Nat Prod. 2011 Apr 25;74(4):718-26. doi: 10.1021/np1007872. Epub 2011 Feb 21. J Nat Prod. 2011. PMID: 21338114 Free PMC article.
References
-
- Ortega A, Blount JF, Manchand PS. J Chem Soc, Perkin Trans. 1982;1:2505–2508.
-
- Valdes LJ, III, Butler WM, Hatfield GM, Paul AG, Koreeda M. J Org Chem. 1984;49:4716–4720.
-
- Baggott MJ, Erowid E, Erowid F, Mendelson JE. Clin Pharmacol Ther. 2004;75:P72.
-
- Gonzalez D, Riba J, Bouso JC, Gomez-Jarabo G, Barbanoj MJ. Drug Alcohol Depend. 2006;85:157–162. - PubMed
-
- Pavarin RM. Ann Ist Super Sanita. 2006;42:477–484. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources